S&P 500   5,130.85 (-0.12%)
DOW   39,004.16 (-0.21%)
QQQ   445.06 (-0.12%)
AAPL   176.62 (-1.69%)
MSFT   412.72 (-0.67%)
META   499.89 (-0.48%)
GOOGL   133.55 (-2.62%)
AMZN   179.42 (+0.67%)
TSLA   196.20 (-3.18%)
NVDA   840.37 (+2.14%)
NIO   5.48 (-5.19%)
AMD   205.00 (+1.16%)
BABA   73.07 (-2.08%)
T   16.90 (-0.47%)
F   12.75 (+2.41%)
MU   94.95 (-0.21%)
CGC   3.17 (-1.25%)
GE   160.22 (+0.99%)
DIS   111.90 (-0.04%)
AMC   4.29 (-1.61%)
PFE   25.85 (-2.78%)
PYPL   60.39 (-0.25%)
XOM   105.72 (-0.11%)
S&P 500   5,130.85 (-0.12%)
DOW   39,004.16 (-0.21%)
QQQ   445.06 (-0.12%)
AAPL   176.62 (-1.69%)
MSFT   412.72 (-0.67%)
META   499.89 (-0.48%)
GOOGL   133.55 (-2.62%)
AMZN   179.42 (+0.67%)
TSLA   196.20 (-3.18%)
NVDA   840.37 (+2.14%)
NIO   5.48 (-5.19%)
AMD   205.00 (+1.16%)
BABA   73.07 (-2.08%)
T   16.90 (-0.47%)
F   12.75 (+2.41%)
MU   94.95 (-0.21%)
CGC   3.17 (-1.25%)
GE   160.22 (+0.99%)
DIS   111.90 (-0.04%)
AMC   4.29 (-1.61%)
PFE   25.85 (-2.78%)
PYPL   60.39 (-0.25%)
XOM   105.72 (-0.11%)
S&P 500   5,130.85 (-0.12%)
DOW   39,004.16 (-0.21%)
QQQ   445.06 (-0.12%)
AAPL   176.62 (-1.69%)
MSFT   412.72 (-0.67%)
META   499.89 (-0.48%)
GOOGL   133.55 (-2.62%)
AMZN   179.42 (+0.67%)
TSLA   196.20 (-3.18%)
NVDA   840.37 (+2.14%)
NIO   5.48 (-5.19%)
AMD   205.00 (+1.16%)
BABA   73.07 (-2.08%)
T   16.90 (-0.47%)
F   12.75 (+2.41%)
MU   94.95 (-0.21%)
CGC   3.17 (-1.25%)
GE   160.22 (+0.99%)
DIS   111.90 (-0.04%)
AMC   4.29 (-1.61%)
PFE   25.85 (-2.78%)
PYPL   60.39 (-0.25%)
XOM   105.72 (-0.11%)
S&P 500   5,130.85 (-0.12%)
DOW   39,004.16 (-0.21%)
QQQ   445.06 (-0.12%)
AAPL   176.62 (-1.69%)
MSFT   412.72 (-0.67%)
META   499.89 (-0.48%)
GOOGL   133.55 (-2.62%)
AMZN   179.42 (+0.67%)
TSLA   196.20 (-3.18%)
NVDA   840.37 (+2.14%)
NIO   5.48 (-5.19%)
AMD   205.00 (+1.16%)
BABA   73.07 (-2.08%)
T   16.90 (-0.47%)
F   12.75 (+2.41%)
MU   94.95 (-0.21%)
CGC   3.17 (-1.25%)
GE   160.22 (+0.99%)
DIS   111.90 (-0.04%)
AMC   4.29 (-1.61%)
PFE   25.85 (-2.78%)
PYPL   60.39 (-0.25%)
XOM   105.72 (-0.11%)

OPKO Health (OPK) Earnings Date, Estimates & Call Transcripts

$0.98
-0.01 (-1.20%)
(As of 09:40 AM ET)

Earnings Summary

Upcoming
Earnings Date
May. 1Estimated
Actual EPS
(Feb. 27)
-$0.09
Consensus EPS
(Feb. 27)
-$0.09
Skip Charts & View Estimated and Actual Earnings Data

OPK Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

OPK Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

OPKO Health Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20242($0.09)($0.08)($0.09)
Q2 20242($0.08)($0.08)($0.08)
Q3 20243($0.08)($0.06)($0.07)
Q4 20242($0.07)($0.06)($0.07)
FY 20249($0.32)($0.28)($0.30)
Q1 20251($0.06)($0.06)($0.06)
Q2 20251($0.05)($0.05)($0.05)
Q3 20252($0.05)($0.02)($0.04)
Q4 20251($0.04)($0.04)($0.04)
FY 20255($0.20)($0.17)($0.19)

OPK Earnings Date and Information

OPKO Health last released its quarterly earnings results on February 27th, 2024. The biotechnology company reported ($0.09) earnings per share for the quarter, hitting the consensus estimate of ($0.09). The business earned $181.90 million during the quarter, compared to analysts' expectations of $177.53 million. Its quarterly revenue was down 1.9% on a year-over-year basis. OPKO Health has generated ($0.25) earnings per share over the last year (($0.25) diluted earnings per share). Earnings for OPKO Health are expected to grow in the coming year, from ($0.29) to ($0.13) per share. OPKO Health has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, May 1st, 2024 based off prior year's report dates.

OPKO Health Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
5/1/2024
Estimated)
------- 
2/27/2024Q4 2023($0.09)($0.09)-($0.09)$177.53 million$181.90 million    
11/6/2023Q3 2023($0.09)($0.11)($0.02)($0.11)$174.78 million$178.60 million    
8/3/2023Q2 2023($0.07)($0.03)+$0.04($0.03)$201.97 million$265.40 million    
5/3/2023Q1 2023($0.07)($0.02)+$0.05($0.02)$193.35 million$237.60 million    
2/23/2023Q4 2022($0.11)($0.11)-($0.11)$168.21 million$185.40 million    
11/8/2022Q3 2022($0.10)($0.11)($0.01)($0.11)$172.68 million$179.70 million
8/4/2022Q2 2022($0.02)($0.04)($0.02)$0.06$326.87 million$309.90 million      
5/9/2022Q1 2022($0.08)($0.08)-($0.08)$331.45 million$329.20 million      
2/24/2022Q4 2021($0.03)($0.11)($0.08)($0.11)$317.26 million$401.30 million    
10/28/2021Q3 2021($0.01)$0.04+$0.05$0.04$302.27 million$385.80 million    
7/29/2021Q2 2021$0.02($0.03)($0.05)($0.03)$457.57 million$442.40 million    
4/28/2021Q1 2021$0.05$0.05-$0.05$503.00 million$545.20 million    












OPKO Health Earnings - Frequently Asked Questions

When is OPKO Health's earnings date?

OPKO Health has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, May 1st, 2024 based off last year's report dates. Learn more on OPK's earnings history.

Did OPKO Health beat their earnings estimates last quarter?

In the previous quarter, OPKO Health (NASDAQ:OPK) reported ($0.09) earnings per share (EPS) to hit the analysts' consensus estimate of ($0.09). Learn more on analysts' earnings estimate vs. OPK's actual earnings.

How can I listen to OPKO Health's earnings conference call?

The conference call for OPKO Health's latest earnings report can be listened to online. Listen to Conference Call

How can I read OPKO Health's conference call transcript?

The conference call transcript for OPKO Health's latest earnings report can be read online. Read Transcript

How much revenue does OPKO Health generate each year?

OPKO Health (NASDAQ:OPK) has a recorded annual revenue of $863.50 million.

How much profit does OPKO Health generate each year?

OPKO Health (NASDAQ:OPK) has a recorded net income of -$188.90 million. OPK has generated -$0.25 earnings per share over the last four quarters.

What is OPKO Health's EPS forecast for next year?

OPKO Health's earnings are expected to grow from ($0.29) per share to ($0.13) per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:OPK) was last updated on 3/4/2024 by MarketBeat.com Staff